MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/aog.0000000000001293

Медицинская библиотека · Obstetrics and gynecology · 2016

Trends in Periodic Surveillance Testing for Early-Stage Uterine Cancer Survivors.

Wright Jason D, Tergas Ana I, Hou June Y, Burke William M, Huang Yongmei, Hu Jim C, Hillyer Grace Clarke, Ananth Cande V, Neugut Alfred I, Hershman Dawn L

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To examine the use of periodic surveillance testing for early-stage endometrial cancer survivors.

METHODS

We performed a population-based analysis using the Surveillance, Epidemiology, and End Results-Medicare database, which was used to identify patients with stage I-II endometrioid endometrial cancer treated from 1992 to 2011. Three surveillance periods (7-18, 19-30, 31-42 months) after hysterectomy were examined. Use of vaginal cytology and imaging were quantified.

RESULTS

We identified 17,638 patients. From 1992 to 2011, the use of chest radiography decreased (46.3-34.2%) during the first surveillance period, whereas imaging with chest computed tomography (CT) (0.9-12.6%), abdominopelvic CT (11.7-24.8%), and positron emission tomography (0-2.9%) increased (P<.001 for all). The use of cytology increased from 68.5% in 1992 to 72.3% in 2007 and then decreased to 66.9% in 2011 (P=.02). The mean number of cytologic samples obtained per patient increased from 1.3 in 1992 to 1.6 in 2008 and then declined to 1.3 in 2011, whereas the mean per patient number of chest CTs (0.02-0.2), abdominopelvic CTs (0.2-0.4), and positron emission tomographies (0-0.03) rose from 1992 to 2011. In 2011, 49.3% underwent radiologic surveillance 7-18 months after diagnosis, whereas 11.9% underwent two or more radiologic assessments in combination with cytology. These findings were similar for surveillance periods 2 and 3.

CONCLUSION

The use of chest radiography has decreased and use of cytology has started to decline. However, the use of more costly imaging modalities is increasing despite a lack of evidence for the efficacy of these tests for early-stage endometrial cancer survivors.

Для цитирования: Wright Jason D, Tergas Ana I, Hou June Y, Burke William M, Huang Yongmei, Hu Jim C, Hillyer Grace Clarke, Ananth Cande V, Neugut Alfred I, Hershman Dawn L. Trends in Periodic Surveillance Testing for Early-Stage Uterine Cancer Survivors.. Obstetrics and gynecology. 2016. DOI: 10.1097/aog.0000000000001293.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.